跨导管结构性心脏病干预和与之相应的左心室尾闭塞:一项最新研究
Kyriakos Dimitriadis1, Nikolaos Pyrpyris1, Konstantinos Aznaouridis1
1First Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens, Hippokration General Hospital, Athens, Greece.
The Canadian journal of cardiology
|September 5, 2024
概括
结合左心房尾阻塞 (LAAO) 与结构性心脏病 (SHD) 程序,提供了一种安全的,单次访问的方法,以预防心房动 (AF) 患者的中风. 该策略旨在减少与长期抗凝药相关的出血风险.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 结构性心脏病 结构性心脏病
背景情况:
- 心房动 (AF) 是心脏膜疾病患者常见的心律失常,增加中风风险.
- 预防AF中风的抗凝血药物可以导致出血并发症,特别是在高危人群中.
- 左心房尾阻塞 (LAAO) 是一种有效的中风预防方法,可缓解出血风险.
研究的目的:
- 审查与LAAO结合的结构性心脏病 (SHD) 程序的安全性和有效性.
- 探索"一站式"方法的潜力,同时管理AF和SHD.
- 为了确定目前的证据,迹象,和未来的方向,结合SHD+LAAO程序.
主要方法:
- 综合SHD+LAAO手术现有临床证据和适应症的审查.
- 对主动脉狭窄症,心肌吐和心房隔膜缺陷等疾病联合干预的安全性和疗效数据的分析.
- 评估在一次会议中执行SHD程序和LAAO的可行性.
主要成果:
- 组合SHD+LAAO程序可以安全地执行,而不会增加不良事件.
- 与传统的抗凝药相比,这种综合方法有可能限制出血风险.
- 证据支持联合手术在预防AF患者中风事件中的有效性.
结论:
- 将LAAO与索引SHD程序相结合是预防AF患者中风的有希望的策略.
- "一站式"的方法提供了一个安全和潜在的更有效的管理途径.
- 需要进一步的研究,以充分阐明这些联合程序的长期益处和最佳应用.
相关概念视频
01:20Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...